Carmignac Portfolio Emergents: Letter from the Fund Managers - Q3 2026

Published on
October 15, 2026
Read time
6 minute(s) read
+29.4%
Year-to-date performance of Carmignac Portfolio Emergents F EUR Acc1, versus +27.6% for its reference indicator2.
+20.0%
3-year annualized performance of Carmignac Portfolio Emergents F EUR Acc, versus +21.1% for its reference indicator.
1.1
Sharpe ratio of the Fund over 3 years versus 0.3 for its reference indicator.

During the third quarter of 2026, Carmignac Portfolio Emergents F EUR Acc declined 2.50%, compared with a 0.28% gain for the reference indicator. Since the beginning of the year, the Fund has returned 29.40%, versus 27.58% for its index.

Market environment

Emerging markets delivered flattish returns for the third quarter of 2026 after the exuberance of the first half, closing the period ~5% off the June highs3. Though beneath this benign headline outcome, the quarter was characterised by unusually high volatility. MSCI EM extended its strong year-to-date performance, but the path was far from straightforward: a violent de-risking episode in North Asian technology during July was followed by a sharp recovery, while higher oil prices, rising global bond yields and renewed geopolitical tensions repeatedly challenged risk appetite. By quarter end, EM had nevertheless continued to outperform developed markets, supported by exceptional earnings growth and a resilient export cycle.

Technology remained the dominant driver. Korea and Taiwan entered the quarter after an extraordinary rally in AI and memory, leaving positioning crowded and the market vulnerable to technical selling. In July, Korea corrected by more than 30% from its June peak as foreign profit taking, and a reversal of leveraged ETF flows from local retail investors amplified concerns around the sustainability of AI momentum. The KOSPI subsequently staged a rebound as strong hyperscaler results, continued memory pricing strength and shareholder-return announcements restored confidence, though the index remains 15% off the highs4.

Importantly, the fundamental backdrop has remained consistently stronger than the price action suggested, as demand continues to significantly outstrip supply. Korean semiconductor exports accelerated sharply through the quarter, inventories at Samsung Electronics and SK Hynix reportedly fell below ten days, the companies signed an increasing proportion of long-term agreements (LTAs) and earnings estimates continued to rise.

Across emerging markets more broadly, 2026 EPS expectations were revised materially higher, while overall EM valuations remain inexpensive at around 10x forward earnings. The AI-related export cycle also broadened beyond Korea and Taiwan into Singapore, Malaysia and Vietnam, reinforcing the importance of emerging markets within the global technology supply chain.

Elsewhere, performance was increasingly influenced and differentiated by exposure to commodities and interest rates. Oil remained elevated for much of the quarter amid renewed Middle East tensions, benefiting parts of Latin America while creating pressure for oil-importing economies. Brazil performed strongly, supported by favourable terms of trade, very high real interest rates and an increasingly market-sensitive election backdrop. At the time of writing, Flavio Bolsonaro has won the first round of the Brazilian election and is now very likely to secure the presidency.

By contrast, Indonesia remained particularly vulnerable to higher global yields, while India continued to lag on higher oil prices and its anti-AI perception, despite resilient economic growth and improving banking-system liquidity.

Domestic activity continued to soften in China, with weak property and household-credit data, while policymakers remained reluctant to deliver a large-scale stimulus package. At the same time, policy support for strategic technology remained strong and the Trump-Xi summit in Washington D.C. towards the end of the quarter reaffirmed a period of relative détente for Sino-US relations. Chinese technology shares nevertheless remained volatile as investors digested heavy AI capital expenditure and an unwind of crowded positions.

The quarter therefore reinforced a key feature of the current EM environment: very strong aggregate earnings growth alongside unusually high dispersion. Some broadening of earnings growth beyond the largest AI beneficiaries is encouraging, but elevated global yields, geopolitical uncertainty and increasingly concentrated market leadership sound notes of caution to what has been a remarkably resilient market.

Performance review

Against this backdrop, the fund ended the quarter lower. Atypically for the fund, stock selection was a source of relative weakness this quarter, largely due to holdings in China, whilst the rotation in South Korea also detracted. This was partly offset by positive stock selection in Taiwan and Mexico, and by our underweight exposure to India, where both allocation and selection contributed positively on a relative basis.

At the sector level, Industrials was the main detractor, reflecting weakness across several of our AI infrastructure and electric-vehicle holdings. SK Square, CATL and Hans CNC weighed on performance due, respectively to rotation in Korean memory, fears changes in the EU-China trade relationship and profit taking on strong performance and high expectations. For each of these businesses we continue to believe fundamentals remain strong.

Our Technology holdings contributed positively to our performance, despite considerable volatility. Taiwan was the strongest area of stock selection, led by Asia Vital Components, which was the fund's largest positive contributor, alongside Bizlink. Samsung Electronics preferred shares were another important positive contributor, validating our strategy of positioning in the highly discounted preference shares, which grant the exposure to exactly the same asset and underlying business as the common shares, but at a ~30% discount, and with higher shareholder returns.

Brazil was a modest detractor on a relative basis this quarter, despite positive absolute returns, though this has already turned highly favourable at the outset of Q4. BBB Foods in Mexico was a strong, specific contributor as the business continues to deliver outstanding results and operational execution. Hong Kong Exchanges and New Oriental in China/HK were also positive contributors in the quarter.

Overall, the quarter was a reminder that the current opportunity in emerging markets is accompanied by unusually high dispersion and high concentration – a challenging backdrop. Several of our strongest long-term convictions (such as memory) experienced very sharp corrections even as earnings expectations continued to rise. We used this volatility selectively, trimming well at peak levels and adding on pull backs where we believed price moves had become disconnected from fundamentals.

Portfolio changes

Portfolio activity during the quarter reflected two priorities: managing the size and composition of our AI and memory exposure after an exceptional run, and reallocating capital towards new opportunities where we saw more attractive asymmetry and the ability to introduce risk diversifying exposures.

Within memory, we significantly rebalanced positions. We had reduced SK Hynix and SK Square going into Q3, but following the subsequent correction, we added back to SK Square as its discount to SK Hynix widened sharply (beyond 46%)5.

We continued to build selected AI infrastructure positions on weakness, adding to Bizlink, Hans CNC and Montage at different points during the quarter, while initiating a modest position in Grand Process Technology, a beneficiary of strong demand for advanced chip packaging solutions. Conversely, we trimmed Asia Vital Components after a very strong run and signs that liquid-cooling penetration on one major AI project would be slower than expected, though the near-term earnings impact appears limited and our structural thesis remains intact.

In India, we exited Policybazaar and ICICI Lombard early in the quarter, contributing to a significant reduction in the country weighting. We subsequently participated in the IPOs of Manipal Hospitals and Horizon Industrial Parks, and in the long-awaited National Stock Exchange listing. These transactions allowed us add exposure to India, selectively through businesses we view as higher quality, with stronger structural growth and competitive positioning. However, we remain underweight India overall.

In Latin America, we initiated a position in Credicorp and subsequently increased the position following meetings with management. The Peruvian macro story is among the most compelling across emerging markets, combining low public debt, large foreign-exchange reserves and a strong external position with one of the least penetrated banking systems in emerging markets. Credicorp has a leading 35% market share6 and its Yape (digital) platform provides a potentially powerful route to deepen financial penetration at very low funding and distribution costs. We funded part of this addition by trimming Mexican bank, Banorte, where the shares have performed well but the relative opportunity has become less compelling and the fintech strategy has disappointed.

Lastly, we also exited LG Chem following further engagement with management. Despite the potential for an updated Value-Up programme, we saw limited near-term scope for value discovery in the interest of minority shareholders, given management’s continued focus on the petrochemical turnaround.

Outlook for the coming months

The outlook for emerging markets remains compelling, but the third quarter demonstrated that strong fundamentals do not preclude substantial volatility. However, it is certainly worth noting that EM has now delivered its most persistent period of relative outperformance versus developed markets in a decade, while earnings expectations have continued to rise and valuations remain well below long-term averages. This combination remains supportive, particularly as the earnings recovery begins to broaden beyond the largest technology companies.

We retain a strong conviction in the structural AI and memory opportunity. Supply remains constrained, demand continues to broaden across hyperscalers and custom silicon, and cash generation at the leading Korean memory companies is truly exceptional. At the same time, the extraordinary share-price moves and increasing index concentration mean that position sizing matters more than ever. We have therefore continued to manage the exposure actively, rotating between direct memory holdings and discounted vehicles and adding selectively when technical de-risking creates opportunities.

Beyond technology, we see increasing opportunities in markets where strong external balances, high real rates and improving domestic fundamentals can support both currencies and equities. Latin America remains important in this regard. Brazil offers unusually high real yields and favourable terms of trade. We are very encouraged by the burgeoning regime change signalled from the results in the first round of the election s in early October. This potentially marks not just a change of president, but points to a meaningful shift to the centre-right, extending beyond the presidency to a much stronger position in Congress. This should improve governability and increase the likelihood of credible fiscal adjustment, addressing one of the key structural concerns weighing on Brazilian assets. For equities, a more market-friendly policy backdrop and lower fiscal risk could support lower risk premia, lower long-term rates and a broader re-rating of the Brazilian market.

China remains a difficult market for investment, with bifurcated performance between those areas exposed, and those not exposed, to the government’s drive for technology self-sufficiency and renewed regulatory hurdles. However, many valuations look increasingly attractive and we therefore continue to favour selective company-specific opportunities rather than relying on any hope of a broad macro recovery.

Overall, the environment remains well suited to active stock selection. Emerging markets offer superior earnings growth, improving shareholder returns and exposure to some of the most important structural investment themes globally, but these opportunities increasingly coexist uncomfortably with high geopolitical risk, elevated rates and the potential for sharp technical rotations. We think it’s likely that market volatility persists, but will continue to use any gyrations to selectively add to businesses where fundamentals remain intact, while maintaining discipline on valuation, concentration and overall portfolio risk.

1Carmignac Portfolio Emergents F EUR Acc (ISIN : LU0992626480). Past performance is not necessarily indicative of future performance. Performances are net of fees (excluding possible entrance fees charged by the distributor).
2Reference indicator: MSCI EM NR USD (Reinvested net dividends rebalanced quarterly).
3Source: Bloomberg 30/09/2026.
4Source: Bloomberg 30/09/2026.
5Source: Bloomberg, 08/08/2026.
6Source: Company data, Bloomberg 30/09/2026.
Sources: Carmignac, 30/09/2026.

Carmignac Portfolio Emergents

Grasping promising opportunities within the emerging universe

Carmignac Portfolio Emergents F EUR Acc

ISIN: LU0992626480
Recommended minimum investment horizon
5 years
Risk indicator*
4/7
SFDR - Fund Classification**
Article 9

*Risk Scale from the KID (Key Information Document). Risk 1 does not mean a risk-free investment. This indicator may change over time. **Sustainable Finance Disclosure Regulation (SFDR) 2019/2088. The SFDR classification of the Funds may change over time.

Main risks of the fund

Equity: The Fund may be affected by stock price variations, the scale of which is dependent on external factors, stock trading volumes or market capitalization.
Emerging Markets: Operating conditions and supervision in "emerging" markets may deviate from the standards prevailing on the large international exchanges and have an impact on prices of listed instruments in which the Fund may invest.
Currency: Currency risk is linked to exposure to a currency other than the Fund’s valuation currency, either through direct investment or the use of forward financial instruments.
Discretionary Management: Anticipations of financial market changes made by the Management Company have a direct effect on the Fund's performance, which depends on the stocks selected.
The Fund presents a risk of loss of capital. Please refer to the Fund’s prospectus to view the exhaustive list of risks.

Fees

ISIN: LU0992626480
Entry costs
We do not charge an entry fee. 
Exit costs
We do not charge an exit fee for this product.
Management fees and other administrative or operating costs
1.15% of the value of your investment per year. This estimate is based on actual costs over the past year.
Performance fees
20.00% when the share class overperforms the Reference indicator during the performance period. It will be payable also in case the share class has overperformed the reference indicator but had a negative performance. Underperformance is clawed back for 5 years. The actual amount will vary depending on how well your investment performs. The aggregated cost estimation above includes the average over the last 5 years, or since the product creation if it is less than 5 years.
Transaction Cost
0.39% of the value of your investment per year. This is an estimate of the costs incurred when we buy and sell the investments underlying the product. The actual amount varies depending on the quantity we buy and sell.

Performance

ISIN: LU0992626480
Carmignac Portfolio Emergents+29.4+23.6+5.5+9.8−14.3−10.3+44.9+25.5−18.2+19.8
Reference Indicator+27.6+17.8+14.7+6.1−14.9+4.9+8.5+20.6−10.3+20.6
Carmignac Portfolio Emergents+20.0%+8.1%+9.4%
Reference Indicator+21.2%+9.4%+9.0%

Source: Carmignac at Sep 30, 2026.
Past performance is not necessarily indicative of future performance. Performances are net of fees (excluding possible entrance fees charged by the distributor). The Fund presents a risk of loss of capital.
The return may increase or decrease as a result of currency fluctuations, for the shares which are not currency-hedged.

Reference Indicator: MSCI EM NR index

Marketing communication. Please refer to the KID/KIID, prospectus of the fund before making any final investment decisions. This document is intended for professional clients.

This material may not be reproduced, in whole or in part, without prior authorisation from the Management Company. This material does not constitute a subscription offer, nor does it constitute investment advice. This material is not intended to provide, and should not be relied on for, accounting, legal or tax advice. This material has been provided to you for informational purposes only and may not be relied upon by you in evaluating the merits of investing in any securities or interests referred to herein or for any other purposes. The information contained in this material may be partial information and may be modified without prior notice. They are expressed as of the date of writing and are derived from proprietary and non-proprietary sources deemed by Carmignac to be reliable, are not necessarily all-inclusive and are not guaranteed as to accuracy. As such, no warranty of accuracy or reliability is given and no responsibility arising in any other way for errors and omissions (including responsibility to any person by reason of negligence) is accepted by Carmignac, its officers, employees or agents.

Past performance is not necessarily indicative of future performance. Performances are net of fees (excluding possible entrance fees charged by the distributor). The return may increase or decrease as a result of currency fluctuations, for the shares which are not currency-hedged.

Reference to certain securities and financial instruments is for illustrative purposes to highlight stocks that are or have been included in the portfolios of funds in the Carmignac range. This is not intended to promote direct investment in those instruments, nor does it constitute investment advice. The Management Company is not subject to prohibition on trading in these instruments prior to issuing any communication. The portfolios of Carmignac funds may change without previous notice. The reference to a ranking or prize, is no guarantee of the future results of the UCIS or the manager.

Morningstar Rating™ : © Morningstar, Inc. All Rights Reserved. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.

Access to the Funds may be subject to restrictions regarding certain persons or countries. This material is not directed to any person in any jurisdiction where (by reason of that person’s nationality, residence or otherwise) the material or availability of this material is prohibited. Persons in respect of whom such prohibitions apply must not access this material. Taxation depends on the situation of the individual. The Funds are not registered for retail distribution in Asia, in Japan, in North America, nor are they registered in South America. Carmignac Funds are registered in Singapore as restricted foreign scheme (for professional clients only). The Funds have not been registered under the US Securities Act of 1933. The Funds may not be offered or sold, directly or indirectly, for the benefit or on behalf of a «U.S. person», according to the definition of the US Regulation S and FATCA.
The risks, fees and ongoing charges are described in the KID (Key Information Document). The KID must be made available to the subscriber prior to subscription. The subscriber must read the KID. Investors may lose some or all their capital, as the capital in the funds are not guaranteed. The Funds present a risk of loss of capital.

The Funds’ prospectus, KIDs, NAVs and annual reports are available at www.carmignac.com/en, or upon request to the Management Carmignac Portfolio refers to the sub-funds of Carmignac Portfolio SICAV, an investment company under Luxembourg law, conforming to the UCITS Directive. The French investment funds (fonds communs de placement or FCP) are common funds in contractual form conforming to the UCITS or AIFM Directive under French law.

  • In the United Kingdom: the Funds’ respective prospectuses, KIIDs and annual reports are available at www.carmignac.com/en-gb, or upon request to the Management Company, or for the French Funds, at the offices of the acilities Agent, Carmignac UK Ltd, 2 Carlton House Terrace, London, SW1Y 5AF. This document was prepared by Carmignac Gestion, Carmignac Gestion Luxembourg or Carmignac UK Ltd. FP Carmignac ICVC (the “Company”) is an Investment Company with variable capital incorporated in England and Wales under registered number 839620 and is authorised by the FCA with effect from 4 April 2019 and launched on 15 May 2019. FundRock Partners Limited is the Authorised Corporate Director (the “ACD”) of the Company and is authorised and regulated by the FCA. Registered Office: Hamilton Centre, Rodney Way, Chelmsford, Essex, CM1 3BY, UK; Registered in England and Wales with number 4162989. Carmignac Gestion Luxembourg SA has been appointed as the Investment Manager and distributor in respect of the Company. Carmignac UK Ltd (Registered in England and Wales with number 14162894) has been appointed as a sub-Investment Manager of the Company and is authorised and regulated by the Financial Conduct Authority with FRN:984288.

  • In Switzerland: the prospectus, KIDs and annual report are available at www.carmignac.com/en-ch, or through our representative in Switzerland, CACEIS (Switzerland), S.A., Route de Signy 35, CH-1260 Nyon. The paying agent is CACEIS Bank, Montrouge, Nyon Branch / Switzerland, Route de Signy 35, 1260 Nyon.

  • In Belgium: This document is intended for professional clients. This content has not been validated by FSMA. The decision to invest in the promoted fund should take into account all its characteristics or objectives as described in its prospectus. This communication is published by Carmignac Gestion S.A., a portfolio management company approved by the Autorité des Marchés Financiers (AMF) in France, and its Luxembourg subsidiary Carmignac Gestion Luxembourg, S.A., an investment fund management company approved by the Commission de Surveillance du Secteur Financier (CSSF). “Carmignac” is a registered trademark. “Investing in your Interest” is a slogan associated with the Carmignac trademark. This document does not constitute advice on any investment or arbitrage of transferable securities or any other asset management or investment product or service. The information and opinions contained in this document do not take into account investors’ specific individual circumstances and must never be interpreted as legal, tax or investment advice. The information contained in this document may be partial and could be changed without notice. This document may not be reproduced in whole or in part without prior authorisation. The risks and fees are described in the KID (Key Information Document). The prospectus, KID, the net asset-values and the latest (semi-) annual management report may be obtained, free of charge, in French or in Dutch, from the management company (tel. +352 46 70 60 1) or by consulting its website or www.fundinfo.com. These materials may also be obtained from Caceis Belgium S.A., the financial service provider in Belgium, at the following address: avenue du port, 86c b320, B-1000 Brussels. The Fund (fonds commun de placement or FCP) is a common fund in contractual form conforming to the UCITS Directive under French law. Access to the Fund may be subject to restrictions regarding certain persons or countries. The Funds are not registered for retail distribution in Asia, in Japan, in North America, nor are they registered in South America. Carmignac Funds are registered in Singapore as restricted foreign scheme (for professional clients only). The Funds have not been registered under the US Securities Act of 1933. The Funds may not be offered or sold, directly or indirectly, for the benefit or on behalf of a «U.S. person», according to the definition of the US Regulation S and FATCA. In case of subscription to a fund subject to Article 19bis of the Belgian Income Tax Code (CIR92), the investor will have to pay, upon redemption of his or her shares, a withholding tax of 30% on the income (in the form of interest, or capital gains or losses) derived from the return on assets invested in debt claims. Distributions are subject to withholding tax of 30% without income distinction. In case of subscription in a French investment fund (fonds commun de placement or FCP), you must declare on tax form, each year, the share of the dividends (and interest, if applicable) received by the Fund. Any complaint may be referred to complaints@carmignac.com or CARMIGNAC GESTION - Compliance and Internal Controls - 24 place Vendôme Paris France or on the website www.ombudsfin.be.

The Management Company can cease promotion in your country anytime. Investors have access to a summary of their rights at section 5 entitled "summary of investor rights" on the following links: UK ; Switzerland ; France ; Luxembourg ; Sweden. Belgium (French) ; Belgium (Dutch)

For Carmignac Portfolio Long-Short European Equities: Carmignac Gestion Luxembourg SA in its capacity as the Management Company for Carmignac Portfolio, has delegated the investment management of this Sub-Fund to White Creek Capital LLP (Registered in England and Wales with number OCC447169) from 2nd May 2024. White Creek Capital LLP is authorised and regulated by the Financial Conduct Authority with FRN : 998349.

Carmignac Private Evergreen refers to the Private Evergreen sub-fund of the SICAV Carmignac S.A. SICAV – PART II UCI, registered with the Luxembourg RCS under number B285278.